Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

19.10
-0.2150-1.11%
Post-market: 19.100.00000.00%19:53 EDT
Volume:1.16M
Turnover:22.33M
Market Cap:2.17B
PE:-7.68
High:19.56
Open:18.94
Low:18.94
Close:19.31
52wk High:30.06
52wk Low:13.41
Shares:113.58M
Float Shares:108.26M
Volume Ratio:0.82
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:4.13
PE(LYR):-7.85

Loading ...

A Look At Immunome (IMNM) Valuation After New Barclays Overweight Coverage

Simply Wall St.
·
May 31

Immunome - Varegacestat Treatment Resulted in Statistically Significant Improvements in Primary and All Key Secondary Efficacy Endpoints

THOMSON REUTERS
·
May 30

Immunome says FDA reviews varegacestat NDA for desmoid tumors

Reuters
·
May 30

Immunome says Phase 3 RINGSIDE trial shows varegacestat cuts desmoid tumor progression or death risk 84%

Reuters
·
May 30

Immunome Is Maintained at Buy by Truist Securities

Dow Jones
·
May 29

Immunome price target raised to $37 from $36 at Truist

TIPRANKS
·
May 28

Immunome Initiated at Overweight by Barclays

Dow Jones
·
May 28

Barclays Initiates Immunome at Overweight With $36 Price Target

MT Newswires Live
·
May 28

Immunome (IMNM) Receives a New Rating from Barclays

TIPRANKS
·
May 28

Immunome management presents at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial

TIPRANKS
·
May 23

Stock Track | Immunome Inc. Soars 6.28% in Pre-market on Insider Buying

Stock Track
·
May 19

Immunome director Jean Jacques Bienaime buys 5,000 shares for $103,500

Reuters
·
May 19

LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
May 16

Immunome Is Maintained at Outperform by Leerink Partners

Dow Jones
·
May 16

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Aveanna Healthcare Holdings (AVAH) and QT Imaging Holdings (QTI)

TIPRANKS
·
May 14

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 13

Immunome (IMNM) Gets a Buy from Guggenheim

TIPRANKS
·
May 13

Immunome Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

Immunome reports Q1 EPS (48c), consensus (54c)

TIPRANKS
·
May 13